Wilmer Leigh Thompson

Plus aucun poste en cours

Profil

W.
Leigh Thompson Jr., was a Director of Medarex, Inc. from April 12, 1996, and holds Directorships in Bioanalytical Systems, Inc., DepoMed, Inc., Guilford Pharmaceuticals, Inc., Inspire Pharmaceuticals, Inc., La Jolla Pharmaceuticals, Inc. and Sontra Medical Corporation, all publicly traded biopharmaceutical companies.
He is currently President and Chief Executive Officer of Profound Quality Resources Ltd., consultants to the health care industry.
From 1982 until 1994, he worked at Eli Lilly and Company, retiring as Chief Scientific Officer.
He was a Professor of Medicine at Indiana University and Case Western Reserve University and Assistant Professor of Medicine and Pharmacology and Experimental Therapeutics at The Johns Hopkins Medical Institutions.
He received a B.S.
from the College of Charleston, M.S., Ph.D.
(Pharmacology) and Sc.D.
degrees from the Medical University of South Carolina, an M.D.
degree from The Johns Hopkins University and completed his internal medicine training on the Osler Service at The Johns Hopkins Hospital and as a Staff Associate at the NIH.

Anciens postes connus de Wilmer Leigh Thompson

Sociétés	Poste	Fin
Guilford Pharmaceuticals, Inc.	Directeur/Membre du Conseil	03/10/2005
Inspire Pharmaceuticals, Inc.	Président	11/02/2005
INOTIV, INC.	Directeur/Membre du Conseil	11/01/2005
Eli Lilly & Co. /Indian Tobraneg Operations/	Directeur Technique/Scientifique/R&D	01/01/1994
Case Western Reserve University	Corporate Officer/Principal	-